Aethlon Medical Inc

AEMD:NASDAQ
RT Quote | NASDAQ | USD
Last | 4:00 PM EST
2.66quote price arrow up+0.02 (+0.76%)
Volume
396,822
52 week range
1.18 - 4.34

...

Loading . . .

KEY STATS

  • Open2.64
  • Day High2.74
  • Day Low2.33
  • Prev Close2.64
  • 52 Week High4.34
  • 52 Week High Date01/31/20
  • 52 Week Low1.18
  • 52 Week Low Date05/08/20
  • Market Cap32.16M
  • Shares Out12.09M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta0.66
  • 1 Year % Change10.83

RATIOS/PROFITABILITY

  • EPS (TTM)-0.79
  • P/E (TTM)-3.35
  • Fwd P/E (NTM)-3.72
  • EBITDA (MRQ)-5.80M
  • ROE (MRQ)-83.52%
  • Revenue (MRQ)0.62M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-933.37%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date02/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Aethlon Medical Inc News

There is no recent news for this security.

Latest AEMD News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted...
Edward Broenniman
Chairman
Charles Fisher Jr.
Chief Executive Officer
James Frakes
Chief Financial Officer
Address
9635 Granite Ridge Dr Ste 100
San Diego, CA
92123
United States